Sep 12 2016 Pharmaceutical Industry Leader Ronald M. Burch Joins Relmada Therapeutics Advisory Team View
Sep 07 2016 Relmada Therapeutics to Present at the Rodman & Renshaw 18th Annual Global Investment Conference View
Jun 27 2016 Relmada Therapeutics Announces Notice of Allowance for U.S. Patent Covering d-Methadone, an NMDA Receptor Antagonist, for the Treatment of Depression View
Jun 07 2016 Relmada Therapeutics' d-Methadone Receives Orphan Drug Designation for Management of Postherpetic Neuralgia View
May 16 2016 Relmada Therapeutics Announces Promotion of Michael D. Becker to Chief Financial Officer View
May 04 2016 Relmada Therapeutics Announces Results of In Vivo Study Showing d-Methadone has Antidepressant-like Effects View
